Fremont, CA -- July 31, 2003 -- PerkinElmer Optoelectronics, a global technology leader providing market-driven integrated solutions for biomedical and industrial applications, today announced it has received orders from four global medical lighting companies for its new line of mini-Cermax® Xenon lamps. Launched only six months ago, the mini-Cermax Xenon lamp provides medical lighting manufacturers with long-life, white light (6000 deg K) superior-quality lamps at prices comparable to lower-performing halogen or metal halide systems, and with coveted Xenon technology.

PerkinElmer is a leading supplier for OEM products for endoscopy and microscopy companies, who are striving to make their instruments more compact, lighter and user-friendly. As these medical lighting companies evolve their instruments, they look for partners like PerkinElmer that can design specific components that can support these advancements in medical technology and patient care.

"Manufacturers of medical instruments are demanding cost-effective, bright, white light to produce accurate color solutions, and our miniature Cermax Xenon lamps are ideal for several reasons," said John Murphy, president, PerkinElmer Optoelectronics. "Each of our lamps is designed to fit the specific optical and spatial needs of every customer, and our own design and manufacturing processes produces very customized Xenon solutions in less time and at competitive prices."

Xenon provides the added benefit of being environmentally friendly as it is an inert gas and non-toxic. No organic (carbon-based) materials, mercury, rare-earth elements, or any other materials with disposal problems are used in its construction.

Compared to mercury-based halogen bulbs, which only omit 3200 kelvin in color temperature and limited color quality, xenon allows for 6000 degree kelvin color, true white light and true color rendition. The result for the end user is a less intrusive instrument and the improved color quality allows for more accurate displays of tissue and fields of study during less invasive surgical procedures.

About Cermax Xenon Lamps
PerkinElmer's Cermax Xenon lamps provide a balanced D6500 / D5900 color spectrum and true white light to produce accurate, brilliant colors. For medical companies, benefits include superior color and contrast ratios, which contribute to accurate color contrast, which helps medical professionals in diagnosis.

PerkinElmer Optoelectronics has successfully implemented enhancements to its design and manufacturing processes that enable it to produce high-quality, long-lasting lamp engines at competitive prices. PerkinElmer is working closely with its manufacturing customers to help them reduce design costs, speed time to market, and create competitive advantage.

Factors Affecting Future Performance

This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as "believes," "intends," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) our failure to introduce new products in a timely manner; (2) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (3) fluctuations in the global economic and political environments; (4) markets into which we sell our products decline or do not grow as anticipated; (5) our failure to adequately protect our intellectual property; (6) the loss of any of our licenses or licensed rights; (7) our ability to compete effectively; (8) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (9) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (10) disruptions in the supply of raw materials and supplies; (11) our ability to produce an adequate quantity of products to meet our customers' demands; (12) the manufacture and sale of products may expose us to product liability claims; (13) our failure to maintain compliance with applicable government regulations; (14) regulatory changes; (15) our failure to comply with health care industry regulations; (16) economic, political and other risks associated with foreign operations; (17) our ability to retain key personnel; (18) restrictions in our credit agreements; (19) our ability to realize the full value of our intangible assets; (20) significant fluctuations in our stock price; and (21) other factors which we describe under the caption "Risk Factors" in our most recent annual report on Form 10-K and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

About PerkinElmer, Inc.

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2 billion in 2008, has around 8,500 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.

		For Further Information:
		Media Contact: Kristen Kmetetz Porter Novelli Life Sciences 617.897.8272 (office) Kristen.kmetetz@porternovelli.com or Francine S. Bernitz Marketing Director, Illumination and Detection Solutions PerkinElmer, Inc. Francine.bernitz@perkinelmer.com 978.224.4321 (office) 781.789.3178 (cell)